Reply to F. Valcamonico et al.
Publication
, Journal Article
Smith, MR; Halabi, S; Small, EJ
Published in: J Clin Oncol
November 10, 2014
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
November 10, 2014
Volume
32
Issue
32
Start / End Page
3685
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Male
- Imidazoles
- Humans
- Diphosphonates
- Bone Neoplasms
- Bone Density Conservation Agents
- Adenocarcinoma
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, M. R., Halabi, S., & Small, E. J. (2014). Reply to F. Valcamonico et al. J Clin Oncol, 32(32), 3685. https://doi.org/10.1200/JCO.2014.57.3808
Smith, Matthew R., Susan Halabi, and Eric J. Small. “Reply to F. Valcamonico et al.” J Clin Oncol 32, no. 32 (November 10, 2014): 3685. https://doi.org/10.1200/JCO.2014.57.3808.
Smith MR, Halabi S, Small EJ. Reply to F. Valcamonico et al. J Clin Oncol. 2014 Nov 10;32(32):3685.
Smith, Matthew R., et al. “Reply to F. Valcamonico et al.” J Clin Oncol, vol. 32, no. 32, Nov. 2014, p. 3685. Pubmed, doi:10.1200/JCO.2014.57.3808.
Smith MR, Halabi S, Small EJ. Reply to F. Valcamonico et al. J Clin Oncol. 2014 Nov 10;32(32):3685.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
November 10, 2014
Volume
32
Issue
32
Start / End Page
3685
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Male
- Imidazoles
- Humans
- Diphosphonates
- Bone Neoplasms
- Bone Density Conservation Agents
- Adenocarcinoma
- 3211 Oncology and carcinogenesis